Endometriosis and quality of life

Czech version

Authors: Peter Koliba; D. Kužel; M. Fanta
Authors‘ workplace: Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha, přednosta prof. MUDr. A. Martan, DrSc.
Published in: Ceska Gynekol 2017; 82(5): 411-418

Overview

Objective:
This article aims to provide a comprehensive overview of the possibilities of evaluating the impact of symptoms of endometriosis on quality of life of affected women and to overview the effect of treatment modalities in improving of the quality of their life.

Design:
Review article.

Setting:
Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague.

Methods:
Review of results of published studies evaluating quality of life in patients with endometriosis.

Conclusion:
Symptoms of endometriosis decrease the quality of life of affected women, which has significant impact on society. Since the extent of endometriosis does not correlate with subjective complaints, it is suitable to evaluate the quality of life of patients in addition to assessment of the extent and classification of the disease (according to internationally accepted classification). The quality of life could be measured and compared by structured interviews or by validated questionnaires. Pharmacological as well as surgical treatment significantly improve quality of life of patients with endometriosis. Routine use of validated questionnaires of quality of life in patients with endometriosis might improve the assessment of severity of the disease and evaluation of effectiveness of the treatment in the future.

Keywords:
endometriosis, deep infiltrating endometriosis, quality of life, health-related quality of life, QOL, HrQOL, pelvic pain, questionnaires

Sources

1. Abbott, JA., Hawe, J., Clayton, RD., et al. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2–5 year follow-up. Hum Reprod, 2003, 18, p. 1922–1927.

2. Abou-Setta, AM., Houston, B., Al-Inany, HG., et al. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev. 2013.

3. Barlow, DH., Glynn, CJ. Endometriosis and pelvic pain. Clin Obstet Gynaecol, 1993, 7, p. 775–789.

4. Bassi, MA., Podgaec, S., Dias, JA. Jr., et al. Quality of life after segmental resection of the rectosigmoid by laparoscopy in patients with deep infiltrating endometriosis with bowel involvement. J Minim Invasive Gynecol, 2011, 18(6), p. 730–733.

5. Bhattacharya, SM. Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause. Gynecol Endocrinol, 2009, 25, p. 621–623.

6. Bourdel, N., Alves, J., Pickering, G., et al. Systematic review of endometriosis pain assessment: how to choose a scale? Hum Reprod Update, 2015, 21(1), p. 136–152.

7. Brown, J., Pan, A., Hart, RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010, 12.

8. Caruso, S., Iraci, M., Cianci, S., et al. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. J Endocrinol Invest, 2016, 39(8), p. 923–931.

9. Caruso, S., Iraci, M., Cianci, S., et al. Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest. J Endocrinol Invest, 2015, 38(11), p. 1211–1218.

10. Coulter, A., Peto, V., Jenkinson, C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract, 1994, 11(4), p. 394–401.

11. Crosignani, PG., Luciano, A., Ray, A., et al. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod, 2006, 21, p. 248–256.

12. Darai, E, Dubernard, G., Coutant, C., et al. Randomized trial of laparoscopically assisted versus open colorectal resection for endometriosis: morbidity, symptoms, quality of life, and fertility. Ann Surg, 2010, 251(6), p. 1018–1023.

13. Dragomirecká, E., Bartoňová, J., a kol. Příručka pro uživatele české verze dotazníků kvality života Světové zdravotnické organizace WHOQOL-BREF a WHOQOL-100. Psychiatrické centrum Praha, 2006, 88 s. ISBN 80-85121-82-4.

14. Dubernard, G., Piketty, M., Rouzier, R., et al. Quality of life after laparoscopic colorectal resection for endometriosis. Hum Reprod, 2006, 21(5), p. 1243–1247.

15. Duffy, JM., Arambage, K., Correa, FJ., et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2014, 3.

16. Eskenazi, B., Warner, ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am, 1997, 24, p. 235–258.

17. Fauconnier, A., Chapron, C., Dubuisson, JB., et al. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril, 2002, 78, p. 719–726.

18. Fourquet, J., Baez, L., Figueroa, M., et al. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril, 2011, 96, p. 107–112.

19. Garry, R., Clayton, R., Hawe, J. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators. BJOG, 2000, 107(1), p. 44–54.

20. Grandi, G., Xholli, A., Napolitano, A., et al. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study. Reprod Sci, 2015, 22(5), p. 626–632.

21. Guzick, DS., Huang, LS., Broadman, BA., et al. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril, 2011, 95(5), p. 1568–1573.

22. Jia, Shuang-zheng, et al. Health-related quality of life in women with endometriosis: a systematic review. J Ovarian Res, 2012, 5, p. 29. PMC. Web. 13 Dec. 2015.

23. Jones, G., Jenkinson, C., Kennedy, S. Development of the short form Endometriosis Health Profile Questionnaire: the EHP-5. Qual Life Res, 2004, 13, p. 695–704.

24. Jones, G., Kennedy, S., Barnard, A., et al. Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30. Obstet Gynecol, 2001, 98(2), p. 258–264. PubMed PMID: 11506842.

25. Mabrouk, M., Montanari, G., Guerrini, M., et al. Does laparoscopic management of deep infiltrating endometriosis improve quality of life? A prospective study. Health and quality of life outcomes, 2011, 9, p. 98.

26. Marques, A., Bahamondes, L., Aldrighi, JM., et al. Quality of life in Brazilian women with endometriosis assessed through a medical outcome questionnaire. J Reprod Med Obstet Gynecol, 2004, 49, p. 115–120.

27. Miller, JD. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial. Am J Obstet Gynecol, 2000, 182(6), p. 1483–1488.

28. Missmer, SA., Hankinson, SE., Spiegelman, D., et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol, 2004, 104, p. 965.

29. Nisenblat, V., Prentice, L., Bossuyt, PMM., et al. Combination of the non-invasive tests for the diagnosis of endometriosis. Cochrane Database of Systematic Rev, 2016, Issue 7. Art. No.: CD012281.

30. Nnoaham, KE., Hummelshoj, L., Webster, P., et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril, 2011, 96(2), p. 366–373.

31. Payne, J., a kol. Kvalita života a zdraví. Praha, Triton, 2005.

32. Pergialiotis, V., Vlachos, D., Protopapas, A., et al. Review of the various laparoscopic techniques used in the treatment of bowel endometriosis. Minerva Ginecol, 2015, 67(4), p. 353–363.

33. Petrelluzzi, KFS., Garcia, MC., Petta, CA., et al. Salivary cortisol concentrations, stress and quality of life in women with endometriosis and chronic pelvic pain. Stress, 2008, 11, p. 390–397.

34. Petta, CA., Ferriani, RA., Abrao, MS., et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod, 2005, 20(7), p. 1993–1998.

35. Proctor, ML., Latthe, PM., Farquhar, CM., et al. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2005, 19;(4):CD001896.

36. Ribeiro, PA., Sekula, VG., Abdalla-Ribeiro, HS., et al. Impact of laparoscopic colorectal segment resection on quality of life in women with deep endometriosis: one year follow-up. Qual Life Res, 2014, 23(2), p. 639–643.

37. Roman, H., Darwish, B., Bridoux, V., et al. Functional outcomes after disc excision in deep endometriosis of the rectum using transanal staplers: a series of 111 consecutive patients. Fertil Steril, 2017, 27. pii: S0015-0282(17)30002-X. [Epub ahead of print]

38. Roman, H., Milles, M., Vassilieff, M., et al. Long-term functional outcomes following colorectal resection versus shaving for rectal endometriosis. Am J Obstet Gynecol, 2016, 215(6), p. 762.e1–762.e9.

39. Roman, H., Moatassim-Drissa, S., Marty, N., et al. Rectal shaving for deep endometriosis infiltrating the rectum: a 5-year continuous retrospective series. Fertil Steril, 2016, 106(6), p. 1438–1445.e2. doi: 10.1016/j.fertnstert.2016.07.1097.

40. Sagsveen, M., Farmer, JE., Prentice, A., et al. Gonadotrophin-releasing hormone analogues for endometriosis: Bone mineral density. Cochrane Database Syst Rev. 2003, 4.

41. Schlaff, WD., Carson, SA., Luciano, A., et al. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril, 2006, 85, p. 314–325.

42. Sepulcri, RP., Do, AV. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol, 2009, 142(1), p. 53–56.

43. Simoens, S., Dunselman, G., Dirksen, C., et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod, 2012, 27(5), p. 1292–1299.

44. Slováček, L., Slováčková, B., Blažek, M., et al. Kvalita života onkologických nemocných – definice, koncepce, možnosti měřeni? Klin Onkol, 2006, 19(3), s. 163–166.

45. Souza, CA., Oliveira, LM., Scheffel, C., et al. Quality of life associated to chronic pelvic pain is independent of endometriosis diagnosis – a cross-sectional survey. Health Qual Life Outcomes, 2011, 9, p. 41.

46. Strowitzki, T., Faustmann, T., Gerlinger, C., et al. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol, 2010.

47. Strowitzki, T., Marr, J., Gerlinger, C., et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod, 2010, 25(3), p. 633–641.

48. Stull, DE., Wasiak, R., Kreif, N., et al. Validation of the SF-36 in patients with endometriosis. Qual Life Res, 201, 23(1), p. 103–117.

49. Tanmahasamut, P., Rattanachaiyanont, M., Angsuwathana, S., et al. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol, 2012, 119(3), p. 519–526.

50. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL). Development and psychometric properties. Soc Sci Med, 1998, 46, p. 1569–1585.

51. Touboul, C., Amate, P., Ballester, M., et al. Quality of Life Assessment Using EuroQOL EQ-5D Questionnaire in patients with deep infiltrating endometriosis: The relation with symptoms and locations. Int J Chronic Dis, 2013.

52. Tripoli, TM., Sato, H., Sartori, MG., et al. Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis. J Sex Med, 2011, 8, p. 497–503.

53. Vercellini, P., Aimi, G., Busacca, M., et al. Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fertil Steril, 2003, 80(2), p. 310–319.

54. Vercellini, P., De Giorgi, O., Mosconi, P., et al. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril, 2002, 77(1), p. 52–61.

55. Vercellini, P., Fedele, L., Aimi, G., et al. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod, 2007, 22, p. 266–271.

56. Vercellini, P., Frattaruolo, MP., Somigliana, E., et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. Hum Reprod, 2013, 28(5), p. 1221–1230.

57. Zullo, F., Palomba, S., Zupi, E., et al. Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: a 1-year prospective randomized double-blind controlled trial. Am J Obstet Gynecol, 2003, 189(1), p. 5–10.

58. Zupi, E., Marconi, D., Sbracia, M., et al. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril, 2004, 82, p. 1303–1308.